您当前的位置：
首页 >
文章列表页 >
Expert Consensus on Prevention and Management of Nausea and Vomiting Associated with CLDN18.2-Targeted Therapeutic Drugs (2026 edition)Antitumor Drug Safety Management Professional Committee of Shanghai Anti-Cancer Association
更新时间：2026-06-15

    • Expert Consensus on Prevention and Management of Nausea and Vomiting Associated with CLDN18.2-Targeted Therapeutic Drugs (2026 edition)Antitumor Drug Safety Management Professional Committee of Shanghai Anti-Cancer Association

    • China Oncology   (2026)

    • Received：08 June 2026，

    移动端阅览

  • 上海市抗癌协会抗肿瘤药物安全管理专业委员会. Expert Consensus on Prevention and Management of Nausea and Vomiting Associated with CLDN18.2-Targeted Therapeutic Drugs (2026 edition)Antitumor Drug Safety Management Professional Committee of Shanghai Anti-Cancer Association[J/OL]. China Oncology, 2026. DOI：

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition)
Chinese expert consensus on standardized management of PI3K/AKT inhibitor-associated hyperglycemia in breast cancer (2026 edition)
Chinese expert consensus on the diagnosis and treatment of leptomeningeal metastasis from breast cancer
Expert consensus on BRCA1/2 gene testing and clinical application in Chinese breast cancer patients (2025 edition)
Comprehensive management strategy of interstitial lung disease induced by trastuzumab deruxtecan

Related Author

Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association
Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association
Cancer Prevention and Clinical Research Committee of Chinese Aging Well Association
Breast Cancer Study Group Along the Yangtze River
Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association
Clinical Cancer Research Evaluation Committee of Chinese Medical Education Association
Chinese Medical Education Association Tumor Drug Clinical Research Professional Committee
Shanghai Anti-Cancer Association Tumor Drug Clinical Research Professional Committee

Related Institution

Committee of Breast Cancer Society, Chinese Anti-Cancer Association; Clinical Precision Medicine Professional Committee, Chinese Medical Doctor Association; Tumor Heterogeneity and Personalized Therapy Professional Committee, Chinese Anti-Cancer Association
Department of Oncology, the First Affiliated Hospital of Chongqing Medical University
Department of Oncology, Qilu Hospital, Shandong University
Department of Oncology, the First Bethune Hospital of Jilin University
Department of Breast Internal Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region
0